clinical trials for semaglutide Semaglutide: The Drug of Today and a Steppingstone to Tomorrow semaglutide 7.2 mg clinical trial

10.1016/0091-3057(75)90053-2 45 HodosW

American Journal of HealthSystem Pharmacy

"Disease is your body screaming at you, asking you to find the root of the disharmony." : This quote underscores the importance of listening to the body's signals and addressing underlying health issues

Semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, is gaining attention not only for its blood glucose-lowering effects but also for its ability to improve liver function and reduce liver fat accumulation, which is particularly beneficial for MASLD patients who often have coexisting T2DM

Personalized programs often provide the resources and support needed to make these lifestyle shifts